Keyphrases
Alzheimer's Disease
100%
Decline Disease
100%
Cognitive Decline
100%
Insulin-like Growth factor-1
100%
IGF Signaling
100%
Intranasal Insulin
36%
Amyloidosis
36%
Mouse Model
27%
Healthy Brain Aging
18%
Insulin
18%
Therapeutic Window
18%
Mixed Dementia
18%
Aging
18%
Vascular Dementia
18%
Intranasal Treatment
9%
Pathological Changes
9%
Dementia
9%
Contradictory Evidence
9%
Metabolic Hormones
9%
Central Action
9%
Intranasal Delivery
9%
Illness
9%
Brain Aging
9%
Tauopathy
9%
Neurodegenerative Diseases
9%
Growth Factors
9%
Valence
9%
BOLD fMRI
9%
Neuroinflammation
9%
Insulin-like
9%
Functional Magnetic Resonance Imaging
9%
Cognitive Aging
9%
Age-related Cognitive Impairment
9%
Growth Hormone
9%
Vascular Dysfunction
9%
Neurodegeneration
9%
Window of Opportunity
9%
Vasculature
9%
Potential Therapeutics
9%
Cognitive Impairment
9%
Signaling Pathway
9%
Intranasal
9%
Synapse
9%
Vascular Amyloid
9%
Beneficial Effects
9%
Aging Process
9%
Etiology
9%
Therapeutic Potential
9%
Central Administration
9%
Brain Diseases
9%
Paucity
9%
Type 2 Diabetes Mellitus (T2DM)
9%
Imaging Approach
9%
IGF-1 Treatment
9%
Neuroscience
Alzheimer's Disease
100%
Amyloidosis
71%
Cognitive Disorders
28%
Neurodegenerative Disorder
14%
Bovine Somatotropin
14%
Functional Magnetic Resonance Imaging
14%
Neurodegeneration
14%
Insulin-Like Growth Factor 1
14%
Cell Signaling
14%
Synapse
14%
Growth Hormone
14%
Tauopathy
14%